(Just the News staff) Pfizer announced Tuesday that a final analysis of its experimental COVID-19 antiviral pill sharply reduced hospitalizations and deaths among people at high risk of severe illness from the virus.
An Agent for Consciousness Evolution
(Just the News staff) Pfizer announced Tuesday that a final analysis of its experimental COVID-19 antiviral pill sharply reduced hospitalizations and deaths among people at high risk of severe illness from the virus.